Lazard Asset Management LLC Adaptive Biotechnologies Corp Transaction History

Lazard Asset Management LLC

$68.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$2.88 - $4.8 $45,463 - $75,772	-15,786 Reduced 8.24%	175,821 $564,000
Q4 2023 Feb 14, 2024	SELL	$3.46 - $5.33 $26,825 - $41,323	-7,753 Reduced 3.89%	191,607 $938,000
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $30,049 - $50,023	-5,927 Reduced 2.89%	199,360 $1.09 Million
Q2 2023 Aug 14, 2023	SELL	$6.19 - $8.78 $1,225 - $1,738	-198 Reduced 0.1%	205,287 $1.38 Million
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $6,996 - $9,068	897 Added 0.44%	205,485 $1.81 Million
Q4 2022 Feb 14, 2023	SELL	$6.26 - $9.34 $1.1 Million - $1.65 Million	-176,229 Reduced 46.28%	204,588 $1.56 Million
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $124,039 - $241,781	19,083 Added 5.28%	380,817 $2.71 Million
Q2 2022 Aug 09, 2022	BUY	$6.4 - $14.73 $799,129 - $1.84 Million	124,864 Added 52.71%	361,734 $2.93 Million
Q1 2022 May 13, 2022	SELL	$10.12 - $28.9 $10.2 Million - $29 Million	-1,004,636 Reduced 80.92%	236,870 $3.29 Million
Q4 2021 Feb 09, 2022	BUY	$25.17 - $36.85 $1.74 Million - $2.55 Million	69,230 Added 5.91%	1,241,506 $34.8 Million
Q3 2021 Nov 15, 2021	BUY	$30.02 - $39.87 $937,284 - $1.24 Million	31,222 Added 2.74%	1,172,276 $39.8 Million
Q2 2021 Aug 12, 2021	BUY	$32.22 - $44.59 $6.61 Million - $9.14 Million	205,040 Added 21.91%	1,141,054 $46.6 Million
Q1 2021 May 14, 2021	BUY	$37.26 - $67.74 $13.5 Million - $24.6 Million	363,221 Added 63.41%	936,014 $37.7 Million
Q4 2020 Feb 11, 2021	SELL	$45.01 - $65.47 $7.81 Million - $11.4 Million	-173,453 Reduced 23.24%	572,793 $33.9 Million
Q3 2020 Nov 13, 2020	SELL	$35.79 - $48.81 $1.6 Million - $2.19 Million	-44,768 Reduced 5.66%	746,246 $36.3 Million
Q2 2020 Aug 13, 2020	BUY	$24.95 - $48.38 $1.1 Million - $2.13 Million	44,118 Added 5.91%	791,014 $38.3 Million
Q1 2020 May 14, 2020	BUY	$16.96 - $34.16 $11.2 Million - $22.6 Million	660,346 Added 762.96%	746,896 $20.7 Million
Q4 2019 Feb 13, 2020	BUY	$24.56 - $32.8 $2.13 Million - $2.84 Million	86,550 New	86,550 $2.59 Million

Others Institutions Holding ADPT

# of Institutions

204

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

Viking Global Investors LP

30M
Shares

$204 Million
0.59% of portfolio
Rubric Capital Management LP New York, NY

14.4M
Shares

$98.1 Million
2.05% of portfolio
Black Rock Inc. New York, NY

11.7M
Shares

$79.4 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

11.6M
Shares

$79 Million
0.56% of portfolio
Vanguard Group Inc Valley Forge, PA

10.6M
Shares

$72.5 Million
0.0% of portfolio

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $973M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account